sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> dysmenorrhea treatment market

report

Dysmenorrhea Treatment Market, by Type of Diseases (Primary Dysmenorrhea, Secondary Dysmenorrhea (Adenomyosis, Uterine Myomas, Endometrial Polyps, Endometriosis, Cervical Stenosis, Obstructive Malformations of Genital Tract)), Therapeutic Class (Non-Hormonal Medical Treatment (Non-Steroidal Anti-Inflammatory Drugs, Over-The-Counter (Otc) Medications), Hormonal Medicine Treatment (Combined Oral Contraceptive, Progestin Regimens, Levonorgestrel Intrauterine System), Surgical Options (Laparoscopy, Hysterectomy, Presacral Neurectomy, Laparoscopic Uterosacral Nerve Ablation, Intrauterine Device)) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC220 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the dysmenorrhea treatment market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the dysmenorrhea treatment market. The scope of this report covers the dysmenorrhea treatment market by its major segments, which include the type of diseases, therapeutic class, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The increasing prevalence of dysmenorrhea, rising awareness among the customers, and the increasing concerns about dysmenorrhea among the females from the developed nations are some of the factors likely to drive the growth of the dysmenorrhea market.
  • The factors, such as the introduction of the innovative drugs and government initiatives with respect to women's health are fuelling the growth of the dysmenorrhea treatment market.
  • However, the complications in the long-term treatment and the side effects associated with the treatment are likely to hamper the growth of the dysmenorrhea market during the forecast period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s dysmenorrhea treatment market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the dysmenorrhea treatment market by the following segments:

  • Dysmenorrhea Treatment Market, by Type of Diseases
    • Adenomyosis
    • Uterine Myomas
    • Endometrial Polyps
    • Endometriosis
    • Cervical Stenosis
    • Obstructive Malformations of Genital Tract
  • Dysmenorrhea Treatment Market, by Therapeutic Class
    • Non-hormonal medical treatment
      • Non-Steroidal Anti-Inflammatory Drugs
      • Over-the-counter (OTC) Medications
    • Hormonal medicine treatment
      • Combined Oral Contraceptive
      • Progestin Regimens
      • Levonorgestrel Intrauterine System
    • Surgical Options
      • Laparoscopy
      • Hysterectomy
      • Presacral Neurectomy
      • Laparoscopic Uterosacral Nerve Ablation
      • Intrauterine Device

KEY MARKET PLAYERS

Key players in the dysmenorrhea treatment market include:

  • Merck
  • Novartis Pharmaceuticals Corporation
  • Bayer AG
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Vantia Ltd
  • Sanofi
  • ALVOGEN
  • Terramedic Incorporated
  • Taj Pharmaceuticals, Ltd

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Dysmenorrhea Treatment Market

TRENDING RELATED REPORT


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. DYSMENORRHEA TREATMENT MARKET, BY TYPE OF DISEASES
    1. Segment Share
    2. Type of Diseases
      1. Primary Dysmenorrhea
      2. Secondary Dysmenorrhea
        1. Adenomyosis
        2. Uterine Myomas
        3. Endometrial Polyps
        4. Endometriosis
        5. Cervical Stenosis
        6. Obstructive Malformations of Genital Tract
  6. DYSMENORRHEA TREATMENT MARKET, BY THERAPEUTIC CLASS
    1. Segment Share
    2. Therapeutic Class
      1. Non-hormonal medical treatment
        1. Non-Steroidal Anti-Inflammatory Drugs
        2. Over-the-counter (OTC) Medications
      2. Hormonal medicine treatment
        1. Combined Oral Contraceptive
        2. Progestin Regimens
        3. Levonorgestrel Intrauterine System
      3. Surgical Options
        1. Laparoscopy
        2. Hysterectomy
        3. Presacral Neurectomy
        4. Laparoscopic Uterosacral Nerve Ablation
        5. Intrauterine Device
  7. DYSMENORRHEA TREATMENT MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type of Diseases
      3. By Therapeutic Class
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type of Diseases
      3. By Therapeutic Class
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type of Diseases
      3. By Therapeutic Class
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East and Africa
      2. By Type of Diseases
      3. By Therapeutic Class
  8. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2015
    2. Key Innovators
  9. KEY MARKET PLAYERS
    1. Merck
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Novartis Pharmaceuticals Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Bayer AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. F. Hoffmann-La Roche Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Vantia Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Sanofi
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. ALVOGEN
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Terramedic Incorporated
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Taj Pharmaceuticals, Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us